Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 12:07 pm Purchase |
2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 3,092,218 8.700% |
450,000 (+17.03%) |
Filing History |
| 2021-02-16 12:05 pm Sale |
2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
EcoR1 Capital LLC | 156,135 7.500% |
-39,659 (-20.26%) |
Filing History |
| 2021-02-16 12:02 pm Purchase |
2020-12-31 | 13G | Morphic Holding, Inc. MORF |
EcoR1 Capital LLC | 2,839,884 9.100% |
685,039 (+31.79%) |
Filing History |
| 2021-02-16 12:00 pm Sale |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital LLC | 1,773,037 2.700% |
-2,468,916 (-58.20%) |
Filing History |
| 2021-02-16 11:58 am Sale |
2020-12-31 | 13G | Geron Corporation GERN |
EcoR1 Capital LLC | 28,555,310 8.900% |
-290,844 (-1.01%) |
Filing History |
| 2021-02-16 11:56 am Purchase |
2020-12-31 | 13G | Atreca, Inc. BCEL |
EcoR1 Capital LLC | 2,426,685 8.100% |
945,274 (+63.81%) |
Filing History |
| 2021-02-16 11:54 am Purchase |
2020-12-31 | 13G | Akouos, Inc. AKUS |
EcoR1 Capital LLC | 1,975,984 5.700% |
1,975,984 (New Position) |
Filing History |
| 2021-02-16 09:49 am Unchanged |
2020-12-31 | 13G | Savara Inc. SVRA |
EcoR1 Capital LLC | 3,040,540 5.300% |
0 (Unchanged) |
Filing History |
| 2021-02-12 5:48 pm Sale |
2020-12-31 | 13G | Savara Inc. SVRA |
EcoR1 Capital LLC | 3,040,540 5.300% |
-1,432,664 (-32.03%) |
Filing History |
| 2021-02-12 5:33 pm Sale |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
EcoR1 Capital LLC | 600,000 3.600% |
-415,400 (-40.91%) |
Filing History |
| 2021-02-12 5:23 pm Sale |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
EcoR1 Capital LLC | 93,416 0.200% |
-2,235,076 (-95.99%) |
Filing History |
| 2021-02-12 5:19 pm Sale |
2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
EcoR1 Capital LLC | 76,628 2.100% |
-153,257 (-66.67%) |
Filing History |
| 2021-02-12 4:15 pm Purchase |
2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
EcoR1 Capital LLC | 365,008 5.400% |
132,744 (+57.15%) |
Filing History |
| 2021-02-12 4:06 pm Sale |
2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL |
EcoR1 Capital LLC | 0 0.000% |
-2,248,306 (Position Closed) |
Filing History |
| 2021-02-12 3:58 pm Sale |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
EcoR1 Capital LLC | 0 0.000% |
-2,536,156 (Position Closed) |
Filing History |
| 2021-02-12 3:52 pm Sale |
2020-12-31 | 13G | Merus N.V. MRUS |
EcoR1 Capital LLC | 0 0.000% |
-1,906,861 (Position Closed) |
Filing History |
| 2021-02-12 3:42 pm Sale |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
EcoR1 Capital LLC | 0 0.000% |
-2,909,800 (Position Closed) |
Filing History |
| 2021-02-12 3:36 pm Sale |
2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
EcoR1 Capital LLC | 0 0.000% |
-3,627,597 (Position Closed) |
Filing History |
| 2021-02-12 3:27 pm Unchanged |
2020-12-31 | 13G | Chiasma, Inc. CHMA |
EcoR1 Capital LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-12 3:18 pm Sale |
2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
EcoR1 Capital LLC | 1,509,812 3.500% |
-577,500 (-27.67%) |
Filing History |